RU2441668C2 - Новые визуализирующие агенты - Google Patents

Новые визуализирующие агенты Download PDF

Info

Publication number
RU2441668C2
RU2441668C2 RU2008146031/15A RU2008146031A RU2441668C2 RU 2441668 C2 RU2441668 C2 RU 2441668C2 RU 2008146031/15 A RU2008146031/15 A RU 2008146031/15A RU 2008146031 A RU2008146031 A RU 2008146031A RU 2441668 C2 RU2441668 C2 RU 2441668C2
Authority
RU
Russia
Prior art keywords
imaging
agent
collagen
pharmaceutical composition
cbp
Prior art date
Application number
RU2008146031/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008146031A (ru
Inventor
Сала ЧЕТТИБИ (GB)
Сала ЧЕТТИБИ
Бен НЬЮТОН (GB)
Бен НЬЮТОН
Метт ХАСБИН (NO)
Метт ХАСБИН
Магне СОЛЬБАККЕН (NO)
Магне СОЛЬБАККЕН
Питер ИВСОН (GB)
Питер ИВСОН
Джейн БРАУН (GB)
Джейн БРАУН
Раджив БХАЛЛА (GB)
Раджив БХАЛЛА
Дэниэл КРАМЕР (US)
Дэниэл КРАМЕР
Original Assignee
Джи-И Хелткер Лимитед
Джи-И Хелткер АС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джи-И Хелткер Лимитед, Джи-И Хелткер АС filed Critical Джи-И Хелткер Лимитед
Publication of RU2008146031A publication Critical patent/RU2008146031A/ru
Application granted granted Critical
Publication of RU2441668C2 publication Critical patent/RU2441668C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
RU2008146031/15A 2006-05-25 2007-05-25 Новые визуализирующие агенты RU2441668C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0610395.6 2006-05-25
GBGB0610395.6A GB0610395D0 (en) 2006-05-25 2006-05-25 Novel imaging agents

Publications (2)

Publication Number Publication Date
RU2008146031A RU2008146031A (ru) 2010-06-27
RU2441668C2 true RU2441668C2 (ru) 2012-02-10

Family

ID=36687722

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008146031/15A RU2441668C2 (ru) 2006-05-25 2007-05-25 Новые визуализирующие агенты

Country Status (8)

Country Link
US (1) US8304388B2 (enExample)
EP (1) EP2026844A2 (enExample)
JP (1) JP2009537624A (enExample)
CN (1) CN101454026B (enExample)
BR (1) BRPI0711937A2 (enExample)
GB (1) GB0610395D0 (enExample)
RU (1) RU2441668C2 (enExample)
WO (1) WO2007138291A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5604305B2 (ja) * 2007-12-13 2014-10-08 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬
HUE044239T2 (hu) 2008-03-27 2019-10-28 Purdue Research Foundation Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik
JP2010215572A (ja) * 2009-03-17 2010-09-30 Japan Health Science Foundation 歯髄炎診断マーカー及び歯髄炎診断システム
WO2011128931A1 (ja) * 2010-04-12 2011-10-20 財団法人ヒューマンサイエンス振興財団 歯髄炎診断マーカー及び歯髄炎診断システム
US9173919B2 (en) * 2011-02-16 2015-11-03 Purdue Research Foundation Collagen-targeted nanoparticles
US9217016B2 (en) 2011-05-24 2015-12-22 Symic Ip, Llc Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
EP2970509B1 (en) 2013-03-15 2020-05-13 Purdue Research Foundation Extracellular matrix-binding synthetic peptidoglycans
US20140294901A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide dimer antagonists
US20140294902A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide antagonists
WO2015164822A1 (en) 2014-04-25 2015-10-29 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
CA2949215C (en) 2014-05-16 2023-03-14 Protagonist Therapeutics, Inc. .alpha.4.beta.7 integrin thioether peptide antagonists
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
WO2016054445A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. Novel cyclic monomer and dimer peptides having integrin antagonist activity
JP2017535527A (ja) 2014-10-01 2017-11-30 プロタゴニスト セラピューティクス， インコーポレイテッド 新規のα４β７ペプチド単量体及び二量体拮抗薬
EP3250240A4 (en) * 2015-01-30 2018-10-10 University of Utah Research Foundation Dimeric collagen hybridizing peptides and methods of using
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3009834A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2017184683A1 (en) * 2016-04-21 2017-10-26 The Board Of Regents Of The University Of Taxas System Methods and compositions for detecting aneurysms
WO2018022937A1 (en) 2016-07-27 2018-02-01 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
WO2019010484A2 (en) 2017-07-07 2019-01-10 Symic Ip, Llc SYNTHETIC BIOCONJUGATES
WO2019044894A1 (ja) * 2017-08-31 2019-03-07 学校法人早稲田大学 コラーゲンへの結合活性を有する環状ペプチド
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
WO2019157268A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
CA3104418A1 (en) 2018-07-12 2020-01-16 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
AU2020311395A1 (en) 2019-07-10 2022-02-03 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
MX2022008740A (es) 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie
AU2021383828A1 (en) 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor
KR20240034224A (ko) 2021-07-14 2024-03-13 얀센 바이오테크 인코포레이티드 인터류킨-23 수용체의 지질화된 펩티드 억제제

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741670A (en) * 1992-04-10 1998-04-21 The General Hospital Corporation Cartilage matrix protein and methods for use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972890A (en) 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US7488792B2 (en) 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
GB0326546D0 (en) 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
GB0327494D0 (en) 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents
WO2005082941A1 (en) 2004-02-27 2005-09-09 The University Of Western Ontario Bone sialoprotein collagen-binding peptides
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
GB0421308D0 (en) * 2004-09-24 2004-10-27 Amersham Plc Enzyme inhibitor imaging agents
AU2005307195A1 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741670A (en) * 1992-04-10 1998-04-21 The General Hospital Corporation Cartilage matrix protein and methods for use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Thomas M. Chiang et al. "A Synthetic Peptide Derived from the Sequence of a Type I Collagen Receptor Inhibits Type I Collagen-mediated Platelet Aggregation", The Journal of Clinical Investigation, Volume 100, number 8, October 1997, 2079-2084. Thomas M. Chiang et al. "Cloning, Characterization, and Functional Studies *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes

Also Published As

Publication number Publication date
CN101454026A (zh) 2009-06-10
US8304388B2 (en) 2012-11-06
BRPI0711937A2 (pt) 2012-07-24
WO2007138291A2 (en) 2007-12-06
RU2008146031A (ru) 2010-06-27
JP2009537624A (ja) 2009-10-29
US20090191123A1 (en) 2009-07-30
CN101454026B (zh) 2012-12-12
WO2007138291A3 (en) 2008-05-29
EP2026844A2 (en) 2009-02-25
GB0610395D0 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
BRPI0507684A (pt) agentes de contraste para formação de imagem de perfusão miocárdica
EP2260858A3 (en) Monomethylvaline compounds capable of conjugation to ligands
RU2008146031A (ru) Новые визуализирующие агенты
CA2452923A1 (en) Peptide-based compounds for targeting integrin receptors
BRPI0510487A (pt) agentes de contraste para estudo por imagens de perfusão do miocárdio
EP2305316A3 (en) Diphosphorylated glycopeptide imaging agent for fibrosis
EP2044960A3 (en) Phospholipid analogues for the treatment and diagnosis of cancers
EP2468776A3 (en) Anti-Robo4 antibodies and uses therefor
WO2011094337A8 (en) Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
EP2211913A4 (en) SYSTEMIC ADMINISTRATION OF CHLOROTOXIN AGENTS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS
EP4541418A3 (en) Assays for diagnosing and evaluating treatment options for fabry disease
EP2626368A3 (en) Insulin-oligomer conjugates, formulations and uses thereof
JP2009537624A5 (enExample)
EA200300507A1 (ru) Радиофармацевтические агенты для диагностики болезни альцгеймера
DOP2006000154A (es) Composiciones que contienen partículas magnéticas de óxido de hierro, y uso de dichas composiciones en métodos de diagnóstico por imágenes
MY163136A (en) Peptide radiotracer compositions
PA8684301A1 (es) Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imágenes
ATE555814T1 (de) Radioaktive mittel für die in vivo pet-bildgebung von ccr5
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
GB2431346B (en) A combination composition comprising paracetamol and ibuprofen
BRPI0518328A2 (pt) agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica
TW200642696A (en) Glycopeptide composition
BRPI0515894A (pt) agente de formação de imagem, composições farmacêutica e radiofarmacêutica, conjugado de um inibidor de metaloproteinase matricial com um ligando, precursor para a preparação da composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem
WO2008026051A3 (en) 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature
GB0403856D0 (en) Composition

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130526